Torsten Hechler

780 total citations
40 papers, 573 citations indexed

About

Torsten Hechler is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Torsten Hechler has authored 40 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Immunology. Recurrent topics in Torsten Hechler's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (10 papers) and Silymarin and Mushroom Poisoning (9 papers). Torsten Hechler is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (10 papers) and Silymarin and Mushroom Poisoning (9 papers). Torsten Hechler collaborates with scholars based in Germany, United States and Switzerland. Torsten Hechler's co-authors include Andreas Pahl, Christian Lutz, Michael Kulke, Martin Löchelt, Jan Anderl, Christoph Müller, Heinz Faulstich, Felicitas Pfeifer, Jacek Kuźmak and Magdalena Materniak-Kornas and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and Blood.

In The Last Decade

Torsten Hechler

36 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torsten Hechler Germany 14 242 231 178 96 67 40 573
Ioannis Kagiampakis United States 14 151 0.6× 621 2.7× 56 0.3× 98 1.0× 37 0.6× 25 1000
Yoichiro Tanaka Japan 13 65 0.3× 289 1.3× 85 0.5× 207 2.2× 33 0.5× 40 691
Sébastien Apcher France 17 371 1.5× 611 2.6× 25 0.1× 299 3.1× 143 2.1× 32 946
Daniela Saggioro Italy 20 217 0.9× 333 1.4× 26 0.1× 402 4.2× 45 0.7× 51 981
Pascal Crottet Switzerland 12 104 0.4× 489 2.1× 117 0.7× 199 2.1× 38 0.6× 15 767
Sara Venturini United States 9 94 0.4× 458 2.0× 169 0.9× 279 2.9× 47 0.7× 11 865
Hans Henning von Horsten Germany 9 80 0.3× 350 1.5× 154 0.9× 124 1.3× 16 0.2× 15 784
Yanping Wang China 16 123 0.5× 328 1.4× 84 0.5× 192 2.0× 72 1.1× 32 656
Paul J. Hippenmeyer United States 13 84 0.3× 351 1.5× 25 0.1× 55 0.6× 136 2.0× 21 620
R. Broeze United States 12 152 0.6× 487 2.1× 114 0.6× 342 3.6× 58 0.9× 24 841

Countries citing papers authored by Torsten Hechler

Since Specialization
Citations

This map shows the geographic impact of Torsten Hechler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torsten Hechler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torsten Hechler more than expected).

Fields of papers citing papers by Torsten Hechler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torsten Hechler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torsten Hechler. The network helps show where Torsten Hechler may publish in the future.

Co-authorship network of co-authors of Torsten Hechler

This figure shows the co-authorship network connecting the top 25 collaborators of Torsten Hechler. A scholar is included among the top collaborators of Torsten Hechler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torsten Hechler. Torsten Hechler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vranic, Marija, et al.. (2024). Novel Amanitin-Based Antibody–Drug Conjugates Targeting TROP2 for the Treatment of Pancreatic Cancer. Molecular Cancer Therapeutics. 24(4). 485–496. 3 indexed citations
3.
Hechler, Torsten, et al.. (2024). Site‐Specific Modification of Native IgGs with Flexible Drug‐Load. ChemBioChem. 26(8). e202400511–e202400511. 5 indexed citations
4.
Pelz, Andreas, et al.. (2023). Abstract 2636: Amanitin-based ADCs targeting Guanylyl cyclase C (GCC) as novel therapeutic modality for treatment of colorectal cancer. Cancer Research. 83(7_Supplement). 2636–2636. 1 indexed citations
5.
6.
Li, Yujing, Yifan Sun, Michael Kulke, et al.. (2021). Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science Translational Medicine. 13(580). 26 indexed citations
7.
Decker, Kristin, Christoph Mueller, Ramesh Singh, et al.. (2021). Abstract 921: Combination of antibody-targeted amanitin conjugates (ATAC) with immune checkpoint inhibitors shows synergistic therapeutic effect in vitro and in vivo. Cancer Research. 81(13_Supplement). 921–921. 1 indexed citations
8.
Breunig, Christian, Anja Baumann, Nicola Giesen, et al.. (2020). HDP-101, an Anti-BCMA Antibody–Drug Conjugate, Safely Delivers Amanitin to Induce Cell Death in Proliferating and Resting Multiple Myeloma Cells. Molecular Cancer Therapeutics. 20(2). 367–378. 61 indexed citations
9.
Tian, Ruilin, Priya Choudhry, Torsten Hechler, et al.. (2020). CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Blood Advances. 4(13). 2899–2911. 37 indexed citations
10.
López, P., Christoph Müller, Christian Breunig, et al.. (2019). β-Glucuronidase triggers extracellular MMAE release from an integrin-targeted conjugate. Organic & Biomolecular Chemistry. 17(19). 4705–4710. 13 indexed citations
11.
12.
López, P., Torsten Hechler, Andreas Pahl, et al.. (2018). Synthesis and biological evaluation of RGD and isoDGR peptidomimetic-α-amanitin conjugates for tumor-targeting. Beilstein Journal of Organic Chemistry. 14. 407–415. 29 indexed citations
13.
Breunig, Christian, Nicola Lehners, Anja Baumann, et al.. (2017). Preclinical Evaluation of Hdp-101, a Novel Anti-BCMA Antibody-Drug Conjugate, in Multiple Myeloma. Blood. 130. 3070–3070. 11 indexed citations
14.
Hechler, Torsten, Christoph Müller, Andreas Pahl, & Jan Anderl. (2015). Abstract 633: Amanitin-based ADCs with an improved therapeutic index. Cancer Research. 75(15_Supplement). 633–633. 1 indexed citations
15.
Anderl, Jan, Heinz Faulstich, Torsten Hechler, & Michael Kulke. (2013). Antibody–Drug Conjugate Payloads. Methods in molecular biology. 1045. 51–70. 58 indexed citations
16.
Hechler, Torsten, et al.. (2011). Pattern of seroreactivity against feline foamy virus proteins in domestic cats from Germany. Veterinary Immunology and Immunopathology. 143(3-4). 292–300. 22 indexed citations
17.
Münk, Carsten, et al.. (2009). Restriction of feline retroviruses: Lessons from cat APOBEC3 cytidine deaminases and TRIM5α proteins. Veterinary Immunology and Immunopathology. 134(1-2). 14–24. 17 indexed citations
18.
Hechler, Torsten & Felicitas Pfeifer. (2008). Anaerobiosis inhibits gas vesicle formation in halophilic Archaea. Molecular Microbiology. 71(1). 132–145. 24 indexed citations
19.
Hechler, Torsten, et al.. (2007). Glucose inhibits the formation of gas vesicles in Haloferax volcanii transformants. Environmental Microbiology. 10(1). 20–30. 7 indexed citations
20.
Kletzin, Arnulf, Ana S. Ferreira, Torsten Hechler, et al.. (2005). A Rieske ferredoxin typifying a subtype within Rieske proteins: spectroscopic, biochemical and stability studies. FEBS Letters. 579(5). 1020–1026. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioannis Kagiampakis Breakdown of academic impact, for papers by Yoichiro Tanaka Breakdown of academic impact, for papers by Sébastien Apcher Breakdown of academic impact, for papers by Daniela Saggioro Breakdown of academic impact, for papers by Pascal Crottet Breakdown of academic impact, for papers by Sara Venturini Breakdown of academic impact, for papers by Hans Henning von Horsten Breakdown of academic impact, for papers by Yanping Wang Breakdown of academic impact, for papers by Paul J. Hippenmeyer Breakdown of academic impact, for papers by R. Broeze
Rankless by CCL
2026